232 related articles for article (PubMed ID: 25324359)
1. Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis.
Hruskova Z; Geetha D; Tesar V
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i159-63. PubMed ID: 25324359
[TBL] [Abstract][Full Text] [Related]
2. Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives.
Hruskova Z; Tesar V; Geetha D
Kidney Blood Press Res; 2020; 45(2):157-165. PubMed ID: 32074623
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
Timlin H; Lee SM; Manno RL; Seo P; Geetha D
Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
[TBL] [Abstract][Full Text] [Related]
4. Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis.
Geetha D; Lee SM; Shah S; Rahman HM
J Nephrol; 2017 Feb; 30(1):147-153. PubMed ID: 26646552
[TBL] [Abstract][Full Text] [Related]
5. Renal transplantation in anti-neutrophil cytoplasmic antibody vasculitis.
Geetha D; Kant S
Expert Rev Clin Immunol; 2018 Mar; 14(3):235-240. PubMed ID: 29436872
[TBL] [Abstract][Full Text] [Related]
6. Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist's perspective.
Haris Á; Dolgos S; Polner K
Int Urol Nephrol; 2017 Jan; 49(1):91-102. PubMed ID: 27671907
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant.
Murakami C; Manoharan P; Carter-Monroe N; Geetha D
Transpl Int; 2013 Dec; 26(12):1225-31. PubMed ID: 24118474
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.
Sacri AS; Chambaraud T; Ranchin B; Florkin B; Sée H; Decramer S; Flodrops H; Ulinski T; Allain-Launay E; Boyer O; Dunand O; Fischbach M; Hachulla E; Pietrement C; Le Pogamp P; Stephan JL; Belot A; Nivet H; Nobili F; Guillevin L; Quartier P; Deschênes G; Salomon R; Essig M; Harambat J
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i104-12. PubMed ID: 25676121
[TBL] [Abstract][Full Text] [Related]
10. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
Geetha D; Specks U; Stone JH; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Fessler BJ; Ding L; Tchao NK; Ikle D; Jepson B; Brunetta P; Fervenza FC;
J Am Soc Nephrol; 2015 Apr; 26(4):976-85. PubMed ID: 25381429
[TBL] [Abstract][Full Text] [Related]
11. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft.
Lau D; Summers S; Amos L; Simpson I; Mulley W
Nephrology (Carlton); 2012 Apr; 17 Suppl 1():16-9. PubMed ID: 22497649
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.
Romeu M; Couchoud C; Delarozière JC; Burtey S; Chiche L; Harlé JR; Gondouin B; Brunet P; Berland Y; Jourde-Chiche N
QJM; 2014 Jul; 107(7):545-55. PubMed ID: 24570478
[TBL] [Abstract][Full Text] [Related]
15. Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.
Sagmeister MS; Weiss M; Eichhorn P; Habicht A; Habersetzer R; Fischereder M; Schönermarck U
BMC Nephrol; 2018 Oct; 19(1):270. PubMed ID: 30340563
[TBL] [Abstract][Full Text] [Related]
16. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation in ANCA-associated vasculitis.
Sagmeister MS; Grigorescu M; Schönermarck U
J Nephrol; 2019 Dec; 32(6):919-926. PubMed ID: 31471816
[TBL] [Abstract][Full Text] [Related]
18. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis.
Moran S; Little MA
Curr Opin Rheumatol; 2014 Jan; 26(1):37-41. PubMed ID: 24257368
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
[TBL] [Abstract][Full Text] [Related]
20. Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis.
Mansfield N; Hamour S; Habib AM; Tarzi R; Levy J; Griffith M; Cairns T; Cook HT; Pusey CD; Salama AD
Nephrol Dial Transplant; 2011 Oct; 26(10):3280-6. PubMed ID: 21414973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]